Plasmid Carriage and the Serum Sensitivity of Enterobacteria
Overview
Authors
Affiliations
The carriage of a range of plasmids by rough, serum-sensitive laboratory strains of Escherichia coli made no difference to their reactivity in human serum as determined by two methods. Plasmid-carrying enterobacteria isolated from polluted river water gave a variety of responses to serum. Smooth E. coli river isolate C8 was killed by serum but only after a delay of 1 h, and curing of antibiotic resistance and colicin determinants from this strain led to a small but significant increase in serum sensitivity. Plasmids from eight strains were transferred by conjugation to a cured derivative of C8 (C8(-)Nal(R)), and in six cases a significant increase in the serum resistance of the progeny was observed. Plasmid-mediated enhancement of resistance was particularly marked with plasmids R1 and NR1, and a round of replication mutant of NR1 conferred greater resistance than did the normal R factor. However, R1 and NR1 were unable to modify the serum response of a cured strain (P21(-)Nal(R)) derived from promptly serum-sensitive isolate P21. These findings suggest that lipopolysaccharide O-side chains, the cell surface components responsible for the delay in serum killing, are essential for the expression of plasmid factors that modify sensitivity to serum. Examination of K(A)(-) variants of two isolates indicated that the K(A) antigen has only a marginal effect on the serum response.
Spread of R-plasmids among Escherichia coli causing urinary tract infections.
Hughes C, Bauer E, Roberts A Antimicrob Agents Chemother. 1981; 20(4):496-502.
PMID: 7044292 PMC: 181731. DOI: 10.1128/AAC.20.4.496.
Hughes C, Phillips R, Roberts A Infect Immun. 1982; 35(1):270-5.
PMID: 7033137 PMC: 351025. DOI: 10.1128/iai.35.1.270-275.1982.
Determinants that increase the serum resistance of Escherichia coli.
Taylor P, Robinson M Infect Immun. 1980; 29(1):278-80.
PMID: 6995340 PMC: 551108. DOI: 10.1128/iai.29.1.278-280.1980.
Modification of bacterial serum susceptibility by rifampin.
ALEXANDER W, Cobbs C, Curtiss 3rd R Infect Immun. 1980; 28(3):923-6.
PMID: 6995328 PMC: 551039. DOI: 10.1128/iai.28.3.923-926.1980.
Bactericidal activity of human serum against Escherichia coli chi1776.
ALEXANDER W, Alexander L, Curtiss 3rd R Infect Immun. 1980; 28(3):837-41.
PMID: 6995323 PMC: 551026. DOI: 10.1128/iai.28.3.837-841.1980.